Presentation 2013/6/20
Development of an ADME prediction model starting from the structural formulas of drugs
YUICHI KAWASHI, YEONDAE KWON, SATORU MIYAZAKI,
PDF Download Page PDF download Page Link
Abstract(in Japanese) (See Japanese page)
Abstract(in English) So far, lead compounds have been found rapidly because of the introduction of high throughput screening and combinatorial chemistry. By taking the optimization of pharmacological activity into account, more efficient methods for drug design have been developed. However, the methods based on the optimization of pharmacological activity tend to propose the compounds which have some problems with pharmacokinetic properties such as absorption and metabolism and with the safety. If we could evaluate the pharmacokinetics (ADME) and toxicity in silico, we can have possibility to accelerate the new drug development. In this study, we build an ADME prediction model based on the chemical structure of drugs and pharmacokinetics. In this predition model, we used structure-property parameters (descriptors) obtained from the structure of drugs as explanatory variables and half-life in blood, which is an important pharmacokinetic paramter, as objective variables.
Keyword(in Japanese) (See Japanese page)
Keyword(in English) half-life / Drug structure / ADME prediction
Paper # Vol.2013-BIO-34 No.3
Date of Issue

Conference Information
Committee NC
Conference Date 2013/6/20(1days)
Place (in Japanese) (See Japanese page)
Place (in English)
Topics (in Japanese) (See Japanese page)
Topics (in English)
Chair
Vice Chair
Secretary
Assistant

Paper Information
Registration To Neurocomputing (NC)
Language JPN
Title (in Japanese) (See Japanese page)
Sub Title (in Japanese) (See Japanese page)
Title (in English) Development of an ADME prediction model starting from the structural formulas of drugs
Sub Title (in English)
Keyword(1) half-life
Keyword(2) Drug structure
Keyword(3) ADME prediction
1st Author's Name YUICHI KAWASHI
1st Author's Affiliation Graduate School of Pharmaceutical Sciences, Tokyo University of Science()
2nd Author's Name YEONDAE KWON
2nd Author's Affiliation Department of Medical and Life Science, Faculty of Pharmaceutical Sciences, Tokyo University of Science
3rd Author's Name SATORU MIYAZAKI
3rd Author's Affiliation Department of Medical and Life Science, Faculty of Pharmaceutical Sciences, Tokyo University of Science
Date 2013/6/20
Paper # Vol.2013-BIO-34 No.3
Volume (vol) vol.113
Number (no) 111
Page pp.pp.-
#Pages 5
Date of Issue